VAERS Explorer
Back to explore

Report #2825840

Received Feb 11, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
Age unknown
State
—
Recovered
Unknown
Vaccinated
—
Onset
—
Days to onset
—
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
UNKVACCINE NOT SPECIFIED (NO BRAND NAME)UNKNOWN MANUFACTURERUNK—OT

Symptoms (2)

No adverse eventProduct administered to patient of inappropriate age

Symptom narrative

stated her daughter's friend got flublok and she wasn't 18 yet with no reported adverse event; Initial information received on 07-Feb-2025 regarding an unsolicited valid non-serious case received from a consumer. This case involves an unknown age female patient who had received Influenza Trivalent Recombinant Vaccine [Flublok TIV] and she wasn't 18 yet with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the less than 18 years old patient received a unknown dose of suspect Influenza Trivalent Recombinant Vaccine Solution for injection (strength, expiry date and lot number not reported) via unknown route in unknown administration site as immunization with no reported adverse event (product administered to patient of inappropriate age) (same day latency). Information regarding batch number and expiration date corresponding to the one at time of event occurrence was requested. Reportedly: "Caller refused to provide event information without her friend's approval." Action taken: not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.